4-HO-MALT (4-hydroxy-N-methyl-N-allyltryptamine) is a tryptamine derivative which has been sold as a designer drug, first being detected in Slovenia in 2021.[1][2]
This pharmacology-related article is a stub. You can help Wikipedia by expanding it.